Heyu Biological Technology Corporation
HYBT · OTC
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $198 | $500 | -$435 | $81 |
| Dep. & Amort. | $191 | $189 | $1 | $67 |
| Deferred Tax | $0 | -$10 | -$1 | -$16 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $1,275 | -$1,275 |
| Other Non-Cash | -$485 | -$909 | -$4,441 | -$2,603 |
| Operating Cash Flow | -$96 | -$230 | -$3,602 | -$3,746 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$416 | -$136 | $12,970 | -$10,856 |
| Net Acquisitions | $0 | $0 | -$567 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$42,499 | $42,493 |
| Investing Cash Flow | -$416 | -$136 | -$30,096 | $31,637 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $495 | -$80 | $34,496 | -$29,344 |
| Financing Cash Flow | $495 | -$80 | $34,496 | -$29,344 |
| Forex Effect | $0 | $0 | -$27 | $27 |
| Net Chg. in Cash | -$16 | -$440 | -$66 | -$556 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $271 | $711 | $307 | $863 |
| End Cash | $254 | $271 | $241 | $307 |
| Free Cash Flow | -$512 | -$365 | $9,368 | -$14,602 |